


The objective of this Fund is to achieve income and capital growth through investment primarily in a range of equity and equity-related securities.
| Name | % Net Assets | 
|---|---|
| ConocoPhillips | 2.7% | 
| British American Tobacco plc | 2.5% | 
| Nestle | 2.5% | 
| Centrica plc | 2.2% | 
| AstraZeneca plc | 2.1% | 
| Du Pont | 2.1% | 
| Pepsico Inc | 2.1% | 
| Vodafone Group plc | 2.1% | 
| Philip Morris International | 2.1% | 
| Allianz | 2.0% | 
| Key | % Net Assets | 
|---|---|
| 2.7% | |
| 2.5% | |
| 2.5% | |
| 2.2% | |
| 90.1% | 
| Date | 10-May-2021 | 
|---|---|
| NAV | 242.30p | 
| Currency | GBP | 
| Change | 0.000p | 
| % | n/a | 
| YTD change | 242.30p | 
| YTD % | n/a | 
| Fund Inception | 23/05/2008 | 
|---|---|
| Fund Manager | n/a | 
| TER | 1.77 (28-Feb-2013) | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research